Skip to main content

Day: June 1, 2020

Klépierre today reopens all its French malls

press releaseKlépierre today reopens all its French mallsParis — May 30, 2020                                                     Klépierre, the European leader in shopping malls, today reports that it has reopened all its French shopping centers.The administrative decisions that had ordered the closure of nine shopping malls in the Paris region (Val d’Europe, Créteil Soleil, Belle Épine, Noisy Arcades, Villiers-en-Bière, Le Millénaire, Beau Sevran, Claye-Souilly and Éragny) have been revoked. Hence, as of today, all these malls are welcoming back all its retailers and visitors in the best sanitary conditions.Over the last weeks, Klépierre staff had indeed been actively preparing the full reopening of these malls in the Paris region. Everything has been planned for and organized: staff equipment, floor marking, customer flow signage,...

Continue reading

Klépierre a rouvert l’intégralité de ses centres commerciaux en france

communiqué de presseKlépierre a rouvert l’intégralité de ses centres commerciauxen franceParis, le 30 mai 2020                                                     Klépierre, leader européen des centres commerciaux, annonce l’ouverture complète de l’ensemble de ses centres commerciaux en France.Les arrêtés préfectoraux qui avaient ordonné la fermeture de neuf centres commerciaux (Val d’Europe, Créteil Soleil, Belle Épine, Noisy Arcades, Villiers-en-Bière, Le Millénaire, Beau Sevran, Claye Souilly et Éragny) ont été abrogés. Ils accueillent donc dès aujourd’hui à nouveau tous leurs commerçants et visiteurs dans des conditions sanitaires optimales.Les équipes de Klépierre avaient en effet activement préparé les centres du portefeuille d’Île-de-France qui n’étaient encore que partiellement ouverts à une réouverture totale. Équipement des...

Continue reading

Ideanomics MEG Sales Subsidiary Receives Investment from Qingdao City at 2 Billion RMB valuation

NEW YORK, — Ideanomics, (NASDAQ: IDEX) announced that its MEG Group subsidiary Qingdao Mobile New Energy Vehicle Sales Co. Ltd. has received an initial investment of ¥50 Million RMB (approx. $7.2M US) from Qingdao Xingyang City Investment Co., Ltd. as part of a series of investments valuing the subsidiary at ¥2 Billion RMB (approx. $288M US). The follow-on investments will come as the newly formed MEG-owned sales group realizes sales targets of ¥10 Billion RMB per additional investment tranche of 50 Million RMB, with the full ¥200 Million RMB investment for a 10% stake in Qingdao Mobile New Energy Vehicle Sales Co. Ltd. achieved when gross sales reach ¥30 Billion RMB (approximately $4B US). Ideanomics had previously announced its plans to headquarter its MEG subsidiary in Qingdao, creating a commercial EV hub to showcase the depth...

Continue reading

AGF Management Limited (AGF) Provides Update on Smith & Williamson Prospective Merger

TORONTO, June 01, 2020 (GLOBE NEWSWIRE) — Further to the announcement made April 15, 2020, AGF Management Limited (TSX:AGF.B) confirms today that a revised transaction structure has been agreed for the proposed merger between Tilney and Smith & Williamson to create one of the U.K.’s leading integrated wealth management and professional services group.  The revised transaction structure includes a material new equity investment from funds advised by Warburg Pincus LLC, and a new optimized capital structure for the combined group which has resulted in a lower level of debt.“We are pleased with the revised structure of the proposed merger, which allows us to realize the value of our long-term investment in Smith & Williamson. The extraordinary circumstances created by the COVID-19 pandemic and the resulting economic and valuation...

Continue reading

La Société de Gestion AGF Limitée (AGF) fait le point sur la perspective de fusion de Smith & Williamson

TORONTO, 01 juin 2020 (GLOBE NEWSWIRE) — Pour faire suite à l’annonce du 15 avril 2020, La Société de Gestion AGF Limitée (TSX : AGF.B) confirme aujourd’hui qu’une structure révisée de la transaction a fait l’objet d’une entente aux fins de la fusion proposée de Tilney et de Smith & Williamson, laquelle vise à créer un groupe de premier plan spécialisé dans le domaine des services professionnels et de la gestion intégrée de patrimoine au Royaume-Uni.La structure révisée de la transaction comporte un nouvel investissement boursier substantiel provenant de fonds pour lesquels Warburg Pincus LLC agit à titre de conseiller, de même que d’une nouvelle structure de capitaux optimisée, permettant de réduire le niveau de dette du groupe issu de la fusion.« Nous sommes satisfaits de la structure révisée, quant à la fusion proposée,...

Continue reading

Chi-Med Plans to Submit NDA for Surufatinib Following Pre-NDA Meeting with the U.S. FDA

LONDON, June 01, 2020 (GLOBE NEWSWIRE) — Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) today announces that it has held its pre-New Drug Application (“NDA”) meeting with the U.S. Food and Drug Administration (“FDA”) for surufatinib for the treatment of patients with advanced neuroendocrine tumors (“NET”).  Chi-Med has reached an agreement with the FDA that the completed SANET-ep (non-pancreatic NET) and SANET-p (pancreatic NET) studies, along with existing data from surufatinib in U.S. non-pancreatic and pancreatic NET patients, could form the basis to support a U.S. NDA submission. The FDA granted Fast Track Designation status to surufatinib for the non-pancreatic and pancreatic NET development programs in April 2020.  Chi-Med has initiated preparatory work for the U.S. NDA and intends to utilize a rolling submission...

Continue reading

Mkango Donates State of the Art Anaesthetic Machine to the Mercy James Centre at the Queen Elizabeth Central Hospital in Blantyre Malawi to Assist in Combating COVID 19

LONDON and VANCOUVER, British Columbia, June 01, 2020 (GLOBE NEWSWIRE) — Mkango Resources Ltd. (AIM/TSX-V: MKA) (the “Company” or “Mkango”) is pleased to announce the donation of a new state of the art Mindray WATO EX-20 anaesthetic machine to the Mercy James Centre at the Queen Elizabeth Central Hospital in Blantyre, Malawi.The new anaesthetic machine will help enable the Queen Elizabeth Central Hospital to set up a new operating theatre for emergency operations, specifically for patients who are suspected of having the COVID 19 virus.Mr Alexander Lemon, President of Mkango Resources stated:“We are delighted to donate this anaesthetic machine to the Mercy James Centre at the Queen Elizabeth Central Hospital to help fight the growing pandemic of COVID 19 in Malawi. We hope that it will potentially help save...

Continue reading

ERYTECH Announces Poster Presentations at ASCO 2020 Annual Meeting

LYON, France and CAMBRIDGE, Mass., June 01, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announces the presentation of two posters at the American Society of Clinical Oncology (ASCO) 2020 Virtual Meeting.1.   Trial in Progress Poster for the ongoing Phase 3 TRYbeCA1 trial (Abstract # TPS4666)TRYbeCA-1 is a randomized, controlled Phase 3 clinical trial evaluating eryaspase in second-line metastatic pancreatic cancer. The trial is planned to enroll approximately 500 patients in approximately 100 clinical sites in Europe and the U.S. Eligible patients are randomized 1-to-1 to receive eryaspase in combination with standard chemotherapy (gemcitabine/nab paclitaxel or...

Continue reading

ERYTECH annonce la présentation de posters lors de la conférence annuelle ASCO 2020

LYON, France, 01 juin 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Euronext Paris et Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant des médicaments dans les globules rouges, annonce aujourd’hui avoir présenté deux posters lors de la conférence virtuelle 2020 de l’American Society of Clinical Oncology (ASCO).1.   Poster sur l’étude de phase 3 TRYbeCA1 en cours (Abstract n°TPS4666)TRYbeCA-1 est une étude clinique de phase 3 contrôlée et randomisée évaluant eryaspase en traitement de seconde ligne du cancer métastatique du pancréas. L’essai devrait inclure environ 500 patients dans environ 100 sites cliniques en Europe et aux États-Unis. Dans cet essai, les patients éligibles sont randomisés 1-pour-1 pour recevoir eryaspase en combinaison avec la chimiothérapie...

Continue reading

The Honka Huomen log house at the Tuusula Housing Fair was designed to delight all five senses

The Honka Huomen log house at the Tuusula Housing Fair was designed to delight all five sensesAt the Tuusula Housing Fair 2020, Honkarakenne Ltd, a pioneer in log-house construction, will present its Honka Huomen concept home (property 41), which actively promotes the wellbeing of residents. In the Honka Huomen house, healthy natural materials and ecological log construction are combined with smart technology that improves living quality, and art that inspires all the senses. The house will be available for sale in summer 2020.The Honka Huomen house collection was specifically designed for small urban plots. This compact, L-shaped house embraces a small yard, shielded by other buildings on the plot. Picture windows in the courtyard make the landscape part of the interior. The cool-down room between the sauna wing and the lounge can function...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.